Use of a peptide or antibody in the manufacture of a...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61K 38/00 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) C07K 14/71 (2006.01) C07K 16/32 (2006.01)

Patent

CA 2322592

Methods of treating an individual who has an erbB protein mediated tumor is disclosed. Methods of preventing erbB protein mediated tumors in an individual are disclosed. The methods comprise administering to the individual a nucleic acid molecule that encodes a protein that dimerizes with an erbB protein and that is deficient in tyrosine kinase activity. Composition that comprise such nucleic acid molecules including pharmaceutical compositions are disclosed.

Cette invention, qui a trait à des méthodes de traitement d'une personne atteinte d'une tumeur liée à la protéine erbB, concerne également des méthodes de prévention de ladite tumeur. Cette méthode consiste à administrer à la personne une molécule d'acide nucléique codant une protéine qui subit une dimérisation en présence de la protéine erbB et qui fait montre d'insuffisance en matière d'activité tyrosine kinase. L'invention porte également sur des compositions pharmaceutiques renfermant ces molécules d'acide nucléique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of a peptide or antibody in the manufacture of a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a peptide or antibody in the manufacture of a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a peptide or antibody in the manufacture of a... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1347606

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.